JAKARTA, July 18 (Xinhua) — Indonesia’s Food and Drug Monitoring Agency (BPOM) has issued an emergency use authorization for Paxlovid as a treatment to reduce the severity and mortality in COVID-19 patients.
“Paxlovid is approved to treat adult coronavirus patients who do not require supplemental oxygen and are at high risk for severe COVID-19,” Head of BPOM Penny K. Lukito said in a press release.
Phase